Deutsche Bank’s Windtree Therapeutics Inc WINT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-43,340
Closed -$49K 5341
2017
Q1
$49K Hold
43,340
﹤0.01% 4234
2016
Q4
$54K Sell
43,340
-3
-0% -$6 ﹤0.01% 4336
2016
Q3
$110K Hold
43,343
﹤0.01% 3911
2016
Q2
$83K Sell
43,343
-988
-2% -$2.39K ﹤0.01% 4192
2016
Q1
$74K Buy
44,331
+991
+2% +$2.13K ﹤0.01% 4171
2015
Q4
$129K Hold
43,340
﹤0.01% 3942
2015
Q3
$182K Hold
43,340
﹤0.01% 3841
2015
Q2
$412K Sell
43,340
-15,007
-26% -$211K ﹤0.01% 3509
2015
Q1
$971K Sell
58,347
-30,454
-34% -$600K ﹤0.01% 2896
2014
Q4
$1.44M Sell
88,801
-6,561
-7% -$144K ﹤0.01% 2927
2014
Q3
$2.46M Buy
95,362
+29,227
+44% +$706K ﹤0.01% 2376
2014
Q2
$1.65M Sell
66,135
-4,330
-6% -$111K ﹤0.01% 2572
2014
Q1
$2.12M Sell
70,465
-12,149
-15% -$409K ﹤0.01% 2363
2013
Q4
$2.6M Buy
82,614
+63,071
+323% +$1.97M ﹤0.01% 2139
2013
Q3
$535K Sell
19,543
-10,637
-35% -$258K ﹤0.01% 3438
2013
Q2
$642K Buy
+30,180
New +$743K ﹤0.01% 3006

Other funds holding WINT

Deutsche Bank's WINT Position: Q2 2017 in Review

Deutsche Bank sold out of Windtree Therapeutics Inc (WINT) in Q2 2017, closing a stake of 43,340 shares — an estimated $49K sold.

Deutsche Bank first reported a position in WINT in Q2 2013 and held it in 16 quarters. The position peaked at $2.6M in Q4 2013. 3 funds tracked by Wall St. Rank hold WINT as of Q2 2017.

  • Deutsche Bank reported no remaining Windtree Therapeutics Inc position as of Q2 2017 after selling out during the quarter.
  • Deutsche Bank sold 43,340 Windtree Therapeutics Inc shares in Q2 2017, an estimated $49K.
  • Deutsche Bank first reported a position in Windtree Therapeutics Inc in Q2 2013 and held it in 16 quarters.
  • Deutsche Bank's Windtree Therapeutics Inc position peaked at $2.6M in Q4 2013.
  • 3 funds tracked by Wall St. Rank held Windtree Therapeutics Inc as of Q2 2017.

Based on Deutsche Bank's 13F filing for Q2 2017, filed 11 Aug 2017.